DE3689717T2 - Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung. - Google Patents

Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.

Info

Publication number
DE3689717T2
DE3689717T2 DE3689717T DE3689717T DE3689717T2 DE 3689717 T2 DE3689717 T2 DE 3689717T2 DE 3689717 T DE3689717 T DE 3689717T DE 3689717 T DE3689717 T DE 3689717T DE 3689717 T2 DE3689717 T2 DE 3689717T2
Authority
DE
Germany
Prior art keywords
egg
production
specific antibody
containing substance
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3689717T
Other languages
English (en)
Other versions
DE3689717D1 (de
Inventor
Hideo Tokoro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ghen Corp
Original Assignee
Ghen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61218859A external-priority patent/JPH0753669B2/ja
Application filed by Ghen Corp filed Critical Ghen Corp
Application granted granted Critical
Publication of DE3689717D1 publication Critical patent/DE3689717D1/de
Publication of DE3689717T2 publication Critical patent/DE3689717T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE3689717T 1985-11-25 1986-11-21 Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung. Expired - Lifetime DE3689717T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26410885 1985-11-25
JP61218859A JPH0753669B2 (ja) 1985-11-25 1986-09-17 鶏卵からの特異的抗体含有材料およびその製造方法と用途

Publications (2)

Publication Number Publication Date
DE3689717D1 DE3689717D1 (de) 1994-04-21
DE3689717T2 true DE3689717T2 (de) 1994-10-20

Family

ID=26522788

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3689717T Expired - Lifetime DE3689717T2 (de) 1985-11-25 1986-11-21 Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.

Country Status (7)

Country Link
US (1) US5080895B1 (de)
EP (1) EP0225254B1 (de)
AU (1) AU600240B2 (de)
CA (1) CA1306946C (de)
CH (1) CH0225254H1 (de)
DE (1) DE3689717T2 (de)
ES (1) ES2052496T3 (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
US5919665A (en) * 1989-10-31 1999-07-06 Ophidian Pharmaceuticals, Inc. Vaccine for clostridium botulinum neurotoxin
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
US5736139A (en) * 1989-10-31 1998-04-07 Ochidian Pharmaceuticals, Inc. Treatment of Clostridium difficile induced disease
US5719267A (en) * 1989-10-31 1998-02-17 Ophidian Pharmaceuticals Inc. Clostridial toxin disease therapy
US5648468A (en) * 1990-03-09 1997-07-15 Spaulding; Glenn F. Process for identifying sex associated egg proteins and methods for increasing the probability that the avian offspring will be the desired sex
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
US5585098A (en) * 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
US5814316A (en) * 1994-08-05 1998-09-29 Wisconsin Alumni Research Foundation Compound to mimick a naturally occurring peptide's effect
DE69535209D1 (de) * 1994-08-05 2006-10-12 Wisconsin Alumni Res Found Verwendung von gegen ein Darmpeptid gerichtete Antikörper zur Förderung der Futterverwertung
HUT78048A (hu) 1994-10-24 1999-07-28 Ophidian Pharmaceuticals, Inc. A C. difficile által okozott betegség kezelésére és megelőzésére szolgáló vakcina és antitoxin
US6967088B1 (en) * 1995-03-16 2005-11-22 Allergan, Inc. Soluble recombinant botulinum toxin proteins
DE19518232A1 (de) * 1995-05-12 1996-11-14 Ruediger Dr Schade Aviäre, vitelline, gegen Stützgewebe gerichtete Antikörper
DE19548221C1 (de) * 1995-12-22 1997-05-15 Biotest Pharma Gmbh Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände
EP0826005B1 (de) 1996-03-12 2004-05-12 Ovogenix Immunpharma GmbH Verwendung von aviären, vitellinen, gegen hiv-antigene gerichteten antikörpern zur herstellung pharmazeutischer zubereitungen
US5741489A (en) * 1996-05-24 1998-04-21 Anitox Corporation Passively administered antibody that enhances feed conversion efficiency
US5725873A (en) * 1996-07-22 1998-03-10 Wisconsin Alumni Research Foundation Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
SE9701026D0 (sv) 1997-03-20 1997-03-20 Immun System Ims Ab use of avian antibodies
JP3430853B2 (ja) 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
US7344713B1 (en) * 1997-07-07 2008-03-18 Pimentel Julio L Decreased fat absorption with an anti-lipase antibody
US6086878A (en) * 1997-08-21 2000-07-11 Dcv, Inc. Method of increasing muscle protein and reducing fat in animals
US20050114916A1 (en) * 1998-08-21 2005-05-26 Etches Robert J. Production of proteins in eggs
ATE356878T1 (de) * 1997-08-22 2007-04-15 Univ Guelph Herstellung von proteinen in eiern
US6861572B1 (en) 1997-11-14 2005-03-01 Origen Therapeutics, Inc. Production of proteins in eggs
US7129390B2 (en) * 1997-10-16 2006-10-31 Avigenics, Inc Poultry Derived Glycosylated Interferon Alpha 2b
US6803035B2 (en) * 1998-05-08 2004-10-12 Arkion Life Sciences Anti-diarrheal and method for using the same
US6395273B1 (en) * 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
US7618624B1 (en) 1999-01-07 2009-11-17 Anitox Corporation Weight control using an anti-lipase antibody
DE19910159A1 (de) * 1999-02-26 2000-09-14 Rosemarie Heis Spezifische lgY-Eidotterantikörper, ihre Gewinnung und ihre Verwendung
US6213930B1 (en) * 1999-03-15 2001-04-10 Wisconsin Alumni Research Foundation Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency
US7238351B2 (en) * 1999-07-15 2007-07-03 Peter Nash Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
US7241443B1 (en) * 1999-07-15 2007-07-10 Camas Incorporated Immunogen adherence inhibitor and method of making and using same
US6569447B2 (en) 2000-03-24 2003-05-27 Trouw Nutrition Usa, Llc Combination of plasma and hyperimmunized products for increased performance
US20020044942A1 (en) * 2000-09-18 2002-04-18 Chisolm Biological Laboratory, Llc Transfer factor composition and process for producing same
US6468534B1 (en) * 2000-09-21 2002-10-22 4Life Research, Lc Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
US20060073197A1 (en) * 2004-05-20 2006-04-06 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US20070128253A1 (en) * 2005-04-13 2007-06-07 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US6506413B1 (en) 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
CA2392344A1 (en) * 2001-07-02 2003-01-02 Nutratech Inc. Method for removal of pathogens from a localized environment
EP1476184A4 (de) * 2001-12-28 2006-01-04 Camas Inc Immunogen-haftung und verfahren zu seiner herstellung und verwendung
US7534433B2 (en) * 2002-06-06 2009-05-19 Anitox Corporation Method for improving body weight gain and feed conversion efficiency in animals
AU2002313212A1 (en) * 2002-06-13 2003-12-31 Kabushiki Gaisha Tokaibiken Tailor-made preparation and process for producing the same
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
WO2004017916A2 (en) 2002-08-22 2004-03-04 4Life Research, Lc Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition
CN1819844B (zh) * 2003-02-19 2012-02-22 彼得·纳什 免疫原粘附抑制剂及其制备和使用方法
US9701737B2 (en) * 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
US6866868B1 (en) * 2003-09-15 2005-03-15 4Life Research, Lc Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
US7883701B2 (en) * 2003-12-19 2011-02-08 Wisconsin Alumni Research Foundation Method for enhancing growth or increasing feed efficiency through reducing binding between endotoxin and its receptor in the gastrointestinal tract
US7854942B2 (en) * 2004-04-16 2010-12-21 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
CA2521156A1 (en) * 2005-09-16 2007-03-16 John Hare Antibodies as growth promoting agents
US20090053197A1 (en) * 2006-06-14 2009-02-26 Ramaekers Joseph C Transfer Factor Compositions and Methods
US9125874B2 (en) 2007-11-30 2015-09-08 The Ramaekers Family Trust Administration of transfer factor for improving reproductive health
ES2573636T3 (es) * 2006-10-25 2016-06-09 Wisconsin Alumni Research Foundation Métodos para reducir la absorción de fosfato empleando un anticuerpo anti-Npt2B
US20080102067A1 (en) * 2006-10-25 2008-05-01 Cook Mark E Immunogenic composition
US20100143385A1 (en) * 2006-10-26 2010-06-10 Mark Cook Methods for reducing phosphate absorption
US8282928B2 (en) * 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
WO2008148149A1 (en) * 2007-06-05 2008-12-11 Anadis Ltd Method of treatment or inhibition of enterovirus 71 infection
US9388236B2 (en) * 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
CN101686974A (zh) 2007-07-09 2010-03-31 雀巢产品技术援助有限公司 减轻因环境过敏原导致的过敏症的方法
WO2009035494A2 (en) * 2007-07-30 2009-03-19 The Scripps Research Institute Methods for producing anti-glycan antibodies, vaccines and methods for treating cancer or infectious disease
WO2009039256A1 (en) * 2007-09-18 2009-03-26 Ramaekers Nutrition, Llc Growth factor fraction compositions and methods
EP2278984A4 (de) * 2007-11-30 2013-02-27 Ramaekers Family Trust Zusammensetzungen und verfahren zur verbesserung der fertilität
GB0820259D0 (en) * 2008-11-05 2008-12-10 Mars Inc Composition
EP2566521A4 (de) 2010-05-07 2013-11-27 Camas Inc Immunogen-anhaftung sowie verfahren zu ihrer herstellung und verwendung
NZ612299A (en) 2010-11-23 2016-01-29 Pantheryx Inc Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
DE102011006809A1 (de) * 2011-04-05 2012-10-11 Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg Verwendung eines Mittels aus Antikörpern und/oder Insulin-like growth factor-Antagonisten
MX338863B (es) 2011-12-16 2016-05-01 Inst Politecnico Nacional Metodo de obtencion de extracto dializable de leucocitos.
US11268951B2 (en) * 2017-09-20 2022-03-08 Charles River Laboratories International, Inc. CHO host cell protein assay
AU2022277767A1 (en) 2021-05-17 2023-10-26 Societe Des Produits Nestle Sa Cat food supplements comprising an anti-fel-d1 molecule and an animal digest

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1007568A (en) * 1973-12-13 1977-03-29 Michael C. Attwell Bovine immunoglobulin isolation process
US4550019A (en) * 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
FR2489690A1 (fr) * 1979-05-07 1982-03-12 Coturnix Procede d'obtention de la fraction ovomucoide et d'un extrait d'ovomucoide de l'oeuf de caille, produits ainsi obtenus et leur application a titre de medicament
GB2057451B (en) * 1979-09-05 1983-05-05 South African Inventions Immunological preparations comprising egg yolk antibodies
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
US4402938A (en) * 1980-05-29 1983-09-06 Impro Products, Inc. Food and the method of extracting the same from colostrum and milk
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4534971A (en) * 1982-10-20 1985-08-13 Regents Of The University Of Minnesota Complexation of anthracycline and anthraquinone antibiotics by the apo riboflavin binding protein from eggs

Also Published As

Publication number Publication date
EP0225254A3 (en) 1989-04-26
AU6564886A (en) 1987-05-28
US5080895B1 (en) 1998-03-10
EP0225254A2 (de) 1987-06-10
CH0225254H1 (en) 1998-09-15
US5080895A (en) 1992-01-14
ES2052496T3 (es) 1994-07-16
AU600240B2 (en) 1990-08-09
EP0225254B1 (de) 1994-03-16
DE3689717D1 (de) 1994-04-21
CA1306946C (en) 1992-09-01

Similar Documents

Publication Publication Date Title
DE3689717T2 (de) Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.
DE3576082D1 (de) Verbundelektrode, verfahren zu ihrer herstellung und ihre anwendung.
DE3686649D1 (de) Pyrazol-oxim-derivate, verfahren zu deren herstellung und anwendung.
DE3889353T2 (de) Fein verteiltes Aluminoxan, Verfahren zu seiner Herstellung und seine Verwendung.
ATA901883A (de) Polydom, verfahren zu seiner herstellung und immunodiagnostische verfahren
DE68918183T2 (de) Filterelement und Verfahren zu dessen Herstellung.
DE3576500D1 (de) Carbostyrilverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
DE3482327D1 (de) Lagerstabile einkomponenten-urethan-verbindungen und verfahren zu ihrer herstellung und anwendung.
DE3382425D1 (de) Immobilisierte mikrobenzellen und verfahren zu deren herstellung und deren anwendung.
DE3673852D1 (de) Zeolith-reformierkatalysator und verfahren zu seiner herstellung.
DE3887392D1 (de) Modifiziertes chloriertes Polypropylen, Verfahren zu seiner Herstellung und seine Anwendung.
DE3774437D1 (de) Spirooxazin-verbindungen, photoempfindliche materialien, die diese enthalten und verfahren zur herstellung derselben.
DE3865927D1 (de) Tetrahydroindazolyl-benzoxazine, verfahren zu deren herstellung und deren anwendung.
PT72832B (de) Substituierte alpha-aminocarbonyl-1-benzyl-3,4-dihidroisochino-line verfahren zu deren herstellung und deren verwendung
ATE15125T1 (de) Ameisenkoeder, verfahren zu deren herstellung und deren verwendung.
DE3586602D1 (de) Farbelement und verfahren zu seiner herstellung.
DE3873223D1 (de) Benzoxazinyl-triazol-oxide, verfahren zu deren herstellung und deren anwendung.
DE3483998D1 (de) Magnesiaklinker und verfahren zu seiner herstellung.
DE3585852D1 (de) Faerbematerial und verfahren zu dessen herstellung.
PT78585B (de) 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarbonsaeuren und verfahren zu ihrer herstellung
DE58903604D1 (de) Ammonium- und immoniumverbindungen und verfahren zu ihrer herstellung.
DE3584479D1 (de) Synthetisches fraipontit und verfahren zu seiner herstellung.
ATE11282T1 (de) N-sulfenylierte oximcarbamate, verfahren zu ihrer herstellung und ihre verwendung in schaedlingsbekaempfungsmitteln.
ATE16590T1 (de) 5-trichlormethylisoxazol, ein verfahren zu seiner herstellung und seine verwendung.
ATE15210T1 (de) Peptid, verfahren zu seiner herstellung und seine verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition